← Back to Search
A Window Into The Brain: Tools To Assess Pre-clinical Efficacy Of Biomaterials-based Therapies On Central Nervous System Disorders.
J. Samal, A. L. Rebelo, A. Pandit
Published 2019 · Medicine
Download PDFAnalyze on Scholarcy
Therapeutic conveyance into the brain is a cardinal requirement for treatment of diverse central nervous system (CNS) disorders and associated pathophysiology. Effectual shielding of the brain by the blood-brain barrier (BBB) sieves out major proportion of therapeutics with the exception of small lipophilic molecules. Various nano-delivery systems (NDS) provide an effective solution around this obstacle owing to their small size and targeting properties. To date, these systems have been used for several pre-clinical disease models including glioma, neurodegenerative diseases and psychotic disorders. An efficacy screen for these systems involves a test battery designed to probe into the multiple facets of therapeutic delivery. Despite their wide application in redressing various disease targets, the efficacy evaluation strategies for all can be broadly grouped into four modalities, namely: histological, bio-imaging, molecular and behavioural. This review presents a comprehensive insight into all of these modalities along with their strengths and weaknesses as well as perspectives on an ideal design for a panel of tests to screen brain nano-delivery systems.
This paper references
Mass Spectrometry Imaging in Nanomedicine: Unraveling the Potential of MSI for the Detection of Nanoparticles in Neuroscience.
F. Barré (2017)
NIH Swiss and Black Swiss mice have retinal degeneration and performance deficits in cognitive tests.
Steven J Clapcote (2005)
Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
Chun-Yang Zhuang (2010)
Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue
X. Zhang (2017)
Atorvastatin Induction of VEGF and BDNF Promotes Brain Plasticity after Stroke in Mice
J. Chen (2005)
Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study.
Fernanda Sousa (2010)
Treadmill Locomotion in the Intact and Spinal Mouse
H. Leblond (2003)
Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease.
K. Jellinger (1995)
Inaccuracy and instability of sequential movements in Parkinson's disease
K. E. Martin (2004)
c(RGDyK)-decorated Pluronic micelles for enhanced doxorubicin and paclitaxel delivery to brain glioma
Yukun Huang (2016)
Poly(ε-caprolactone)-Block-poly(ethyl Ethylene Phosphate) Micelles for Brain-Targeting Drug Delivery: In Vitro and In Vivo Valuation
P. Zhang (2010)
Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials.
Yung-Hao Tsou (2017)
Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson’s disease model
Wonseok Choi (2011)
Apomorphine-induced emesis in dogs: differential sensitivity to established and novel dopamine D2/5-HT(1A) antipsychotic compounds.
R. Depoortère (2008)
Albumin nanoparticles for the delivery of gabapentin: preparation, characterization and pharmacodynamic studies.
B. Wilson (2014)
Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery.
A. Trapani (2011)
Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes
Q. Lin (2015)
Formulation and Optimization of Polymeric Nanoparticles for Intranasal Delivery of Lorazepam Using Box-Behnken Design: In Vitro and In Vivo Evaluation
D. Sharma (2014)
Integration of olfactory information in a spatial representation enabling accurate arm choice in the radial arm maze.
P. Lavenex (1996)
Quantitative measurement of muscle strength in the mouse
J. Smith (1995)
Haloperidol-loaded polysorbate-coated polymeric nanocapsules increase its efficacy in the antipsychotic treatment in rats.
D. Benvegnú (2011)
Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures.
B. Turetsky (2007)
Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model
Chunxia Wang (2009)
Mitochondrial therapy for Parkinson’s disease: Neuroprotective pharmaconutrition may be disease-modifying
R. Kones (2010)
Ascorbic acid tethered polymeric nanoparticles enable efficient brain delivery of galantamine: An in vitro-in vivo study
K. R. Gajbhiye (2017)
Theranostic Applications of Nanomaterials in Cancer: Drug Delivery, Image-Guided Therapy, and Multifunctional Platforms
A. Fernandez-Fernandez (2011)
Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?
L. Dépatie (2001)
Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Weilun Ke (2009)
Undernutrition during suckling changes the sensitivity to haloperidol and chlorpromazine in two behavioural measures in weaning rats.
J. Rocha (1997)
Etoposide-incorporated tripalmitin nanoparticles with different surface charge: Formulation, characterization, radiolabeling, and biodistribution studies
L. H. Reddy (2008)
Behavioral tests for preclinical intervention assessment
T. Schallert (2011)
A permanent change in brain function resulting from daily electrical stimulation.
G. V. Goddard (1969)
Inbred mouse strain differences in the establishment of long-term fear memory
S. Balogh (2003)
Nanoencapsulation Improves Relative Bioavailability and Antipsychotic Effect of Olanzapine in Rats.
F. Dimer (2015)
In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space.
R. Thorne (2006)
Development of risperidone liposomes for brain targeting through intranasal route.
Reema Narayan (2016)
Accelerated blood clearance phenomenon upon cross-administration of PEGylated nanocarriers in beagle dogs
C. Wang (2015)
Neuroprotective Potential of Superparamagnetic Iron Oxide Nanoparticles Along with Exposure to Electromagnetic Field in 6-OHDA Rat Model of Parkinson's Disease.
Preeti Umarao (2016)
Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting.
Ming-Jun Tsai (2012)
Persistence of Long-Term Memory Storage Requires a Late Protein Synthesis- and BDNF- Dependent Phase in the Hippocampus
P. Bekinschtein (2007)
Liposome encapsulated of temozolomide for the treatment of glioma tumor: preparation, characterization and evaluation.
J. Gao (2015)
Silver nanoparticles as matrix for MALDI FTICR MS profiling and imaging of diverse lipids in brain.
M. Guan (2018)
Assessment of motor balance and coordination in mice using the balance beam.
T. N. Luong (2011)
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.
S. Kunwar (2010)
Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood–brain barrier
Yung-Chu Chen (2013)
Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake.
R. Tiwari (2011)
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
R. Gabathuler (2010)
Three-dimensional atlas of iron, copper, and zinc in the mouse cerebrum and brainstem.
D. Hare (2012)
Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian rats.
Richa Pahuja (2015)
Polymeric nanoparticle drug delivery technologies for oral delivery applications
Eric M. Pridgen (2015)
Superparamagnetic iron oxide nanoparticles modified with dimyristoylphosphatidylcholine and their distribution in the brain after injection in the rat substantia nigra.
Lichao Su (2017)
Biological and physiological role of reactive oxygen species – the good, the bad and the ugly
L. Zuo (2015)
Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery
Nia M. Harris (2016)
MALDI-MS imaging for the study of tissue pharmacodynamics and toxicodynamics.
E. Patel (2015)
Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles.
B. Wilson (2008)
Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study
Rohini G Madane (2016)
Using Gelatin Nanoparticle Mediated Intranasal Delivery of Neuropeptide Substance P to Enhance Neuro-Recovery in Hemiparkinsonian Rats
Yingzheng Zhao (2016)
The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease.
C. Zhang (2014)
A curcumin-loaded polymeric micelle as a carrier of a microRNA-21 antisense-oligonucleotide for enhanced anti-tumor effects in a glioblastoma animal model.
Xiaonan Tan (2018)
Dynamic changes in the recovery after traumatic brain injury in mice: effect of injury severity on T2-weighted MRI abnormalities, and motor and cognitive functions.
J. Tsenter (2008)
Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
Stefanie Wohlfart (2011)
Convection-enhanced delivery of macromolecules in the brain.
R. Bobo (1994)
A new and rapid colorimetric determination of acetylcholinesterase activity.
G. Ellman (1961)
Solid lipid nanoparticles surface modified with anti-Contactin-2 or anti-Neurofascin for brain-targeted delivery of medicines
Nargess Gandomi (2017)
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid
M. F. Beal (1993)
A genome-wide association study identifies a novel susceptibility locus for the immunogenicity of polyethylene glycol
Chia-Jung Chang (2017)
Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly(lactide) nanoparticles in MPTP-induced Parkinsonism.
Gabriela da Rocha Lindner (2015)
Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy
Z. Chen (2016)
Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate α-synuclein fibrilization
D. A. Bosco (2006)
Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma.
G. Bernal (2014)
A revised Racine's scale for PTZ-induced seizures in rats
A. Lüttjohann (2009)
Astrocytes are active players in cerebral innate immunity.
C. Farina (2007)
Lasting effects on rodent anxiety of a single exposure to a cat
R. Adamec (1993)
Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil
Abdulrahman K Al Asmari (2016)
Behavioural despair in rats: a new model sensitive to antidepressant treatments.
R. Porsolt (1978)
PAMAM Dendrimers Cross the Blood–Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice
Bhairavi Srinageshwar (2017)
Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia
S. Namura (1998)
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
M. Mahmoudi (2011)
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
J. Kreuter (1995)
Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.
U. Ungerstedt (1971)
Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer’s disease: pharmaceutical, biological, and toxicological studies
Y. S. Elnaggar (2015)
Molecular pathophysiology of Parkinson's disease.
D. Moore (2005)
Silver nanoparticles as selective ionization probes for analysis of olefins by mass spectrometry.
Stacy D. Sherrod (2008)
Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.
Y. Zhang (2003)
Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes.
A. Judge (2006)
Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression
D. Yu (2017)
Recent advances in quantitative LA-ICP-MS analysis: challenges and solutions in the life sciences and environmental chemistry
A. Limbeck (2015)
Quantum dots as a platform for nanoparticle drug delivery vehicle design.
C. Probst (2013)
Pluronic F127 and D-α-Tocopheryl Polyethylene Glycol Succinate (TPGS) Mixed Micelles for Targeting Drug Delivery across The Blood Brain Barrier
X. Meng (2017)
Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.
H. Chen (2011)
LA-ICP-MS/MS improves limits of detection in elemental bioimaging of gadolinium deposition originating from MRI contrast agents in skin and brain tissues.
David Clases (2019)
Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges
Dinh Ha (2016)
Nanoparticles: Emerging carriers for drug delivery.
S. R. Mudshinge (2011)
Silica-coated superparamagnetic iron oxide nanoparticles targeting of EPCs in ischemic brain injury.
Q. Li (2013)
The Role of the Iron Stain in Assessing Intracranial Hemorrhage
R. Castellani (2016)
Circling behavior in rats with partial, unilateral nigro-striatal lesions: Effect of amphetamine, apomorphine, and DOPA
F. Hefti (1980)
Angiopep-2-conjugated poly(ethylene glycol)-co- poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats
F. Lu (2017)
TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs.
K. S. Rao (2008)
Sex effects in prepulse inhibition and facilitation of the acoustic startle response: implications for pharmacological and treatment studies
I. Aasen (2005)
Mouse closed head injury model induced by a weight-drop device
M. Flierl (2009)
Early pathologic detection of acute myocardial infarction.
R. Kloner (1981)
Enhanced taupathy and AD-like pathology in aged primate brains decades after infantile exposure to lead (Pb).
S. W. Bihaqi (2013)
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma.
A. Estella-Hermoso de Mendoza (2011)
Novel self-assembled nano-tubular mixed micelles of Pluronics P123, Pluronic F127 and phosphatidylcholine for oral delivery of nimodipine: In vitro characterization, ex vivo transport and in vivo pharmacokinetic studies.
E. B. Basalious (2015)
Electrosteric stealth Rivastigmine loaded liposomes for brain targeting: preparation, characterization, ex vivo, bio-distribution and in vivo pharmacokinetic studies
Sara Nageeb El-Helaly (2017)
Intranasal delivery of asenapine loaded nanostructured lipid carriers: formulation, characterization, pharmacokinetic and behavioural assessment
S. Singh (2016)
Evaluation of the formalin test to assess the analgesic activity of diflunisal in the rat.
C. J. Meunier (1998)
Protective role of free and quercetin-loaded nanoemulsion against damage induced by intracerebral haemorrhage in rats.
A. R. Galho (2016)
Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes.
T. Ishida (2006)
Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
S. Di Gioia (2015)
Modulation of social memory in male rats by neurohypophyseal peptides
R. Dantzer (2004)
In vitro release performance and analgesic activity of endomorphin-1 loaded nanoparticles.
H. Liu (2006)
Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury
I. Khalin (2016)
Apoptosis and caspases in neurodegenerative diseases.
R. Friedlander (2003)
Effect of Baicalin-loaded PEGylated cationic solid lipid nanoparticles modified by OX26 antibody on regulating the levels of baicalin and amino acids during cerebral ischemia-reperfusion in rats.
Zhidong Liu (2015)
Stereotyped responding by schizophrenic patients on a two-choice guessing task.
C. Frith (1983)
Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery
S. Dhawan (2011)
In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles.
Juyoun Jin (2011)
Parametric influences on catalepsy
P. Sanberg (2004)
Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson’s Disease
R. Prediger (2009)
Mouse genetic models for prepulse inhibition: an early review
M A Geyer (2002)
Anatomy and physiology of cerebrospinal fluid.
L. Sakka (2011)
Tat-BMPs-PAMAM conjugates enhance therapeutic effect of small interference RNA on U251 glioma cells in vitro and in vivo.
Lei Han (2010)
Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1-42 in Alzheimer’s disease models
A. Bernardi (2012)
Mechanisms of lipid peroxide formation in animal tissues.
E. D. Wills (1966)
Toxicology and clinical potential of nanoparticles
L. Yildirimer (2011)
Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite.
D. Jollow (1974)
Testing forelimb placing “across the midline” reveals distinct, lesion-dependent patterns of recovery in rats
M. Woodlee (2005)
Quantification of swim patterns in the morris water maze
S. Dalm (2000)
Biodegradable polymers as biomaterials
L. Nair (2007)
Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
K. Gao (2006)
Intranasal Piperine-Loaded Chitosan Nanoparticles as Brain-Targeted Therapy in Alzheimer's Disease: Optimization, Biological Efficacy, and Potential Toxicity.
Y. Elnaggar (2015)
Local Delivery of Nimodipine by Prolonged-Release Microparticles—Feasibility, Effectiveness and Dose-Finding in Experimental Subarachnoid Hemorrhage
D. Hänggi (2012)
Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery.
H. Chen (2010)
Top–down modulation of prepulse inhibition of the startle reflex in humans and rats
L. Li (2009)
Clinically relevant frailty index for mice.
Haiming M Liu (2014)
Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluations.
Ming-Jun Tsai (2011)
Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats
E. C. Stoffel (2003)
Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS.
A. L. Cardoso (2008)
Oxidative stress and mitochondrial dysfunction in Alzheimer's disease.
X. Wang (2014)
Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies
S. Nour (2016)
The MPTP marmoset model of parkinsonism: a multi-purpose non-human primate model for neurodegenerative diseases.
I. Philippens (2010)
Depression: a new animal model sensitive to antidepressant treatments
R. Porsolt (1977)
Chitosan nanoparticles: a promising system in novel drug delivery.
K. Nagpal (2010)
Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery
Miaojing Wu (2016)
A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA.
D. Hwang (2011)
Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes
Yuan-Chin Hsieh (2018)
Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease
A. A. Castro (2012)
Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Y. Zhao (2013)
Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/β-catenin pathway.
S. Tiwari (2014)
A Nanomedicine Transports a Peptide Caspase-3 Inhibitor across the Blood–Brain Barrier and Provides Neuroprotection
H. Karatas (2009)
Glutathione and Parkinson's disease: is this the elephant in the room?
G. Zeevalk (2008)
A method for the routine assessment of fore- and hindlimb grip strength of rats and mice.
Meyer Oa (1979)
Glutathione metabolism and its implications for health.
G. Wu (2004)
Behavioral phenotyping of the MPTP mouse model of Parkinson's disease
M. Sedelis (2001)
Exosomes as drug delivery vehicles for Parkinson's disease therapy.
M. Haney (2015)
Peroxide detoxification by brain cells
R. Dringen (2005)
Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE2 activation
W. Chiu (2010)
Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood–Brain Barrier in a Rat Model of Parkinson's Disease
Young-sook Kang (2016)
Customized lipid-coated magnetic mesoporous silica nanoparticle doped with ceria nanoparticles for theragnosis of intracerebral hemorrhage
Bong Geun Cha (2018)
Biomedical Applications of Biodegradable Polymers.
B. Ulery (2011)
A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia
L. Zhang (2002)
Gold-nanoparticle-based multifunctional amyloid-β inhibitor against Alzheimer's disease.
N. Gao (2015)
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions.
A. Chanan-Khan (2003)
Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
Kun Shao (2010)
Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating
K. Stevens (1991)
Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases
Thomas M. Barchet (2009)
Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.
S. Martins (2013)
Genetically Engineered Microvesicles Carrying Suicide mRNA/Protein Inhibit Schwannoma Tumor Growth
A. Mizrak (2013)
Characterization and utilization of Prussian blue and its pigments.
F. Grandjean (2016)
Expanding the potential of MRI contrast agents through multifunctional polymeric nanocarriers.
I. Craciun (2017)
Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice
F. Pitossi (1997)
Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment
Chenchen Bi (2016)
Body distribution of 3H-labelled dalargin bound to poly(butyl cyanoacrylate) nanoparticles after i.v. injections to mice.
U. Schroeder (2000)
Long‐term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study
W. Poewe (2006)
Internalization of targeted quantum dots by brain capillary endothelial cells in vivo
Sarah Paris-Robidas (2016)
Impaired fear conditioning in Alzheimer’s disease
S. Hamann (2002)
Electromagnetized gold nanoparticles mediate direct lineage reprogramming into induced dopamine neurons in vivo for Parkinson's disease therapy.
Junsang Yoo (2017)
Solid Lipid Nanoparticles as Delivery Systems for Bromocriptine
E. Esposito (2007)
Analysing hippocampal function in transgenic mice: an ethological perspective
R. Gerlai (1999)
Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases.
C. Saraiva (2016)
Standardization of the rat paw formalin test for the evaluation of analgesics
H. Wheeler-Aceto (2005)
Evaluation of Quetiapine Fumarate and its Solid Lipid Nanoparticles as antipsychotic drug in rat model of schizophrenia
M. Said (2017)
Effects of Fish and Grape Seed Oils as Core of Haloperidol-Loaded Nanocapsules on Oral Dyskinesia in Rats
D. Benvegnú (2017)
Behavioral despair in mice: a primary screening test for antidepressants.
R. Porsolt (1977)
Daily rhythm of nociception in rats
A. Christina (2004)
Electroresponsive Nanoparticles Improve Antiseizure Effect of Phenytoin in Generalized Tonic-Clonic Seizures
Y. Wang (2016)
Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects
Y. S. Lee (2011)
Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia.
N. Ahmad (2016)
Oxidative Therapy Against Cancer
M. Miguel (2012)
Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
Z. Cohen (2015)
Wheat germ agglutinin-conjugated liposomes incorporated with cardiolipin to improve neuronal survival in Alzheimer’s disease treatment
Y. Kuo (2017)
Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model
Shuiqin Niu (2017)
Transferrin-conjugated liposomal system for improved delivery of 5-fluorouracil to brain
V. Soni (2008)
Postural stability of Parkinson's disease patients is improved by decreasing rigidity
A. Bartolic (2005)
Drug transfer in the choroid plexus. Multiplicity and substrate specificities of transporters
J. Ghersi-Egea (2004)
Quantitative imaging of platinum based on laser ablation-inductively coupled plasma-mass spectrometry to investigate toxic side effects of cisplatin.
C. Köppen (2015)
Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma.
Lisa Treat (2012)
Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts
Y. Shen (2017)
Detection of Behavioral Impairments Correlated to Neurochemical Deficits in Mice Treated with Moderate Doses of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
J. Tillerson (2002)
Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy.
Tingting Lin (2016)
Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics
Treatment Efficacy of NGF Nanoparticles Combining Neural Stem Cell Transplantation on Alzheimer’s Disease Model Rats
Y. Chen (2015)
Poly(ethylene glycol)-block-poly(d,l-lactide acid) micelles anchored with angiopep-2 for brain-targeting delivery
J. Shen (2011)
Neuroprotective effects of novel phosphatidylglycerol‐based phospholipids in the 6‐hydroxydopamine model of Parkinson's disease
S. Crotty (2008)
Mice with a Homozygous Null Mutation for the Most Abundant Glutathione Peroxidase, Gpx1, Show Increased Susceptibility to the Oxidative Stress-inducing Agents Paraquat and Hydrogen Peroxide*
J. D. de Haan (1998)
Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.
R. Alyautdin (1998)
The antioxidant EPC-K1 attenuates NO-induced mitochondrial dysfunction, lipid peroxidation and apoptosis in cerebellar granule cells.
T. Wei (1999)
A Historical Overview of Magnetic Resonance Imaging, Focusing on Technological Innovations
T. Ai (2012)
Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer’s disease model
Mohammad Yusuf (2013)
Forced swimming test in mice: a review of antidepressant activity
B. Petit-Demoulière (2004)
Delivery of Dual Drug Loaded Lipid Based Nanoparticles across the Blood-Brain Barrier Impart Enhanced Neuroprotection in a Rotenone Induced Mouse Model of Parkinson's Disease.
Paromita Kundu (2016)
Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brain.
Sukrut Somani (2014)
Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice
V. Carola (2002)
Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology.
G. Mittal (2011)
Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles
K. B. Kurakhmaeva (2009)
Mood and Anxiety Related Phenotypes in Mice
T. Gould (2009)
Increasing the Efficiency of Parkinson's Disease Treatment Using a poly(lactic-co-glycolic acid) (PLGA) Based L-DOPA Delivery System
P. Gambaryan (2014)
Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme
N. Inestrosa (1996)
Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions
S. Dunnett (1987)
In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
S. Jose (2014)
Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery.
Yao Qin (2011)
Gelatin nanostructured lipid carriers-mediated intranasal delivery of basic fibroblast growth factor enhances functional recovery in hemiparkinsonian rats.
Yingzheng Zhao (2014)
Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats
The history of cerebral PET scanning
L. Portnow (2013)
Interaction of drug effects with testing procedures in the measurement of catalepsy
M. Stanley (1976)
Transport of Glial Cell Line-Derived Neurotrophic Factor into Liposomes across the Blood-Brain Barrier: In Vitro and in Vivo Studies
Shaoling Wu (2014)
A comparative study of PNIPAM nanoparticles of curcumin, demethoxycurcumin, and bisdemethoxycurcumin and their effects on oxidative stress markers in experimental stroke
Niyaz Ahmad (2013)
Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles
Xin-hua Tian (2011)
Clinical implications of near-infrared fluorescence imaging in cancer.
N. Kosaka (2009)
Social Recognition Task in the Rat
M. Lemaire (2003)
Convection-enhanced delivery for the treatment of glioblastoma.
M. Vogelbaum (2015)
Imaging in the era of molecular oncology
R. Weissleder (2008)
Cerium oxide nanoparticles could ameliorate behavioral and neurochemical impairments in 6-hydroxydopamine induced Parkinson's disease in rats
M. A. Hegazy (2017)
Cholinergic- and neuroleptic-induced catalepsy: modification by lesions in the caudate-putamen.
B. Costall (1971)
Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model
Wg singleton (2017)
Various drug delivery approaches to the central nervous system
S. Pasha (2010)
Safety of real-time convection-enhanced delivery of liposomes to primate brain: A long-term retrospective
M. Krauze (2008)
Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase.
Y. Kono (1978)
Mitigating effect of chrysin loaded solid lipid nanoparticles against Amyloid β25–35 induced oxidative stress in rat hippocampal region: An efficient formulation approach for Alzheimer's disease
Aishwarya Vedagiri (2016)
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
Kanika Madaan (2014)
PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation.
M. Muthu (2009)
Recent Advances in SPECT Imaging
M. Madsen (2007)
Development, optimization and pharmacodynamic assessment of olanzapine based lipidic SNEDDS for proficient management of psychosis
M. Ahsan (2016)
Polysorbate 80‐coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain‐protective effects in rats
Deqing Sun (2015)
Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test
G. Rozas (1997)
Oxidative damage in nucleic acids and Parkinson's disease
Y. Nakabeppu (2007)
Functionalized graphene oxide as a drug carrier for loading pirfenidone in treatment of subarachnoid hemorrhage.
Lijun Yang (2015)
Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation.
M. Muthu (2008)
In vitro/in vivo evaluation of gamma-aminobutyric acid-loadedN,N-dimethylacrylamide-based pegylated polymeric nanoparticles for brain delivery to treat epilepsy
Gülsel Yurtdaş Kırımlıoğlu (2016)
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
K. Hargreaves (1988)
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
M. Geyer (2014)
Mass Spectrometric Imaging of Ceramide Biomarkers Tracks Therapeutic Response in Traumatic Brain Injury.
D. Barbacci (2017)
Albumin Nanoparticles for Brain Delivery: A Comparison of Chemical versus Thermal Methods and in vivo Behavior
M. Bergonzi (2016)
Histochemistry: live and in color.
L. Lavis (2011)
Detection of apoptosis by TUNEL assay.
K. Kyrylkova (2012)
Elevated body swing test: a new behavioral parameter for rats with 6- hydroxydopamine-induced hemiparkinsonism
C. Borlongan (1995)
Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.
U. Ungerstedt (1970)
Chemosensory and hormonal mediation of social memory in male rats.
T. F. Sawyer (1984)
Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment
A. C. Silva (2011)
Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations.
B. Kalyanaraman (2012)
Role of mitochondrial dysfunction in Alzheimer's disease
R. Castellani (2002)
Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy
Shuxin Song (2016)
Long-term administration of green tea catechins prevents age-related spatial learning and memory decline in C57BL/6 J mice by regulating hippocampal cyclic amp-response element binding protein signaling cascade
Q. Li (2009)
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application.
Neda Naseri (2015)
Repeated exposure to cocaine produces long-lasting deficits in the serotonergic stimulation of prolactin and renin, but not adrenocorticotropin secretion.
A. D. Levy (1993)
Advances in strategies to improve drug delivery to brain tumors
H. Newton (2006)
3-Methoxy-4-hydroxyphenylethyleneglycol (MHPG) transport from the spinal cord during spinal subarachnoid perfusion
J. Kessler (1976)
Motor disorder in Huntington's disease begins as a dysfunction in error feedback control
M. Smith (2000)
Angiopep-Conjugated Nanoparticles for Targeted Long-Term Gene Therapy of Parkinson’s Disease
R. Huang (2013)
The relation between fear induced by novel stimulation and exploratory drive.
K. Montgomery (1955)
Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases
C. Tapeinos (2017)
Brain targeted oral delivery of doxycycline hydrochloride encapsulated Tween 80 coated chitosan nanoparticles against ketamine induced psychosis: behavioral, biochemical, neurochemical and histological alterations in mice
M. Yadav (2017)
Cued and Contextual Fear Conditioning for Rodents
P. Curzon (2009)
Reactive Oxygen Radicals in Signaling and Damage in the Ischemic Brain
P. Chan (2001)
An optimized triphenyltetrazolium chloride method for identification of cerebral infarcts.
Chintamani N. Joshi (2004)
A Nanoparticle Carrying the p53 Gene Targets Tumors Including Cancer Stem Cells, Sensitizes Glioblastoma to Chemotherapy and Improves Survival
Sang-soo Kim (2014)
Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies.
S. Martins (2012)
Applications of dendrimers for brain delivery and cancer therapy.
Sukrut Somani (2014)
Recent advances in aliphatic polyesters for drug delivery applications.
K. E. Washington (2017)
Selective Targeting of Brain Tumors with Gold Nanoparticle-Induced Radiosensitization
D. Joh (2013)
Modification of seizure activity by electrical stimulation. II. Motor seizure.
R. Racine (1972)
Elemental imaging of MRI contrast agents: benchmarking of LA-ICP-MS to MRI
J. A. T. Pugh (2012)
Of Mice and Mazes: Similarities Between Mice and Rats on Dry Land But Not Water Mazes
I. Whishaw (1996)
 Preparations and properties of soluble NADH dehydrogenases from cardiac muscle
T. E. King (1967)
Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals.
Yao Qin (2011)
A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery.
Y. Liu (2010)
Response latencies in the tail-flick test depend on tail skin temperature
O. Berge (1988)
Tf-lipoplex-mediated c-Jun silencing improves neuronal survival following excitotoxic damage in vivo.
A. L. Cardoso (2010)
Inhibition of C6 glioma in vivo by combination chemotherapy of implantation of polymer wafer and intracarotid perfusion of transferrin-decorated nanoparticles.
L. Han (2012)
Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration.
Ziyi Wen (2011)
Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route
S. Patel (2011)
The role of tumour necrosis factor, interleukin 6, interferon-γ and inducible nitric oxide synthase in the development and pathology of the nervous system
M. Muñoz-Fernández (1998)
Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer's disease by accelerating the clearance of amyloid-beta.
Qingxiang Song (2014)
Neuroprotection in a 6‐hydroxydopamine‐lesioned Parkinson model using lactoferrin‐modified nanoparticles
R. Huang (2009)
Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury
Yanlu Zhang (2017)
Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain.
M. I. Alam (2012)
The pattern of neurological diseases in elderly people in outpatient consultations in Sub-Saharan Africa
Kuate-Tegueu Callixte (2015)
Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats: Involvement of adenosine A1 and A2A receptors
Rui D S Prediger (2005)
Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
Shadab Md (2013)
Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats
Mayur Bagad (2015)
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
D. Morgan (2000)
Site-Directed Delivery of VEGF-Targeted Liposomes into Intracranial C6 Glioma
S. Shein (2015)
Delivery of large molecules via poly(butyl cyanoacrylate) nanoparticles into the injured rat brain.
Yong Lin (2012)
Prefrontal white matter volume is disproportionately larger in humans than in other primates
P. T. Schoenemann (2005)
A simple quantitative bradykinesia test in MPTP-treated mice.
N. Ogawa (1985)
Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease
B. Wilson (2008)
Automation of the novel object recognition task for use in adolescent rats
J. M. Silvers (2007)
A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Congcong Lin (2014)
Mitochondrial Dysfunction: Different Routes to Alzheimer's Disease Therapy
P. Picone (2014)
Enhanced Therapeutic Potential of Nano-Curcumin Against Subarachnoid Hemorrhage-Induced Blood–Brain Barrier Disruption Through Inhibition of Inflammatory Response and Oxidative Stress
Zong-yong Zhang (2015)
Overexpression of human glutathione peroxidase protects transgenic mice against focal cerebral ischemia/reperfusion damage.
M. Weisbrot-Lefkowitz (1998)
Imaging mass spectrometry.
L. McDonnell (2007)
Limitations on the use of the C57BL/6 mouse in the tail suspension test
A. J. Mayorga (2014)
Decreased body temperature dependent appearance of behavioral despair in the forced swimming test in mice.
I. Arai (2000)
The amphetamine-induced sensitized state as a model of schizophrenia
R. Featherstone (2007)
Chapter 2 – Pharmacokinetics
S. Bardal (2011)
[Liposomes as drug carrier systems. Preparation, classification and therapeutic advantages of liposomes].
M. Budai (2001)
Behavioral impairment in radial-arm maze learning and acetylcholine content of the hippocampus and cerebral cortex in aged mice
S. Ikegami (1994)
Developing injectable nanomaterials to repair the heart.
Mary M Nguyen (2015)
Solubilized delivery of paliperidone palmitate by d-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management
M. Muthu (2016)
Polybutylcyanoacrylate nanoparticles for delivering hormone response element-conjugated neurotrophin-3 to the brain of intracerebral hemorrhagic rats.
Chiu-Yen Chung (2013)
Comparison of four different peptides to enhance accumulation of liposomes into the brain
Yao Qin (2012)
Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer
S. Jahan (2017)
Brain glutathione peroxidase in neurodegenerative disorders.
S. Kish (1986)
Bioimaging of copper alterations in the aging mouse brain by autoradiography, laser ablation inductively coupled plasma mass spectrometry and immunohistochemistry.
L. Wang (2010)
The Open-Field Test: a critical review.
R. Walsh (1976)
Reduction-responsive PEtOz-SS-PCL micelle with tailored size to overcome blood–brain barrier and enhance doxorubicin antiglioma effect
Yuling Li (2017)
Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat
T. Freret (2006)
Differential involvement of the dorsal hippocampus in passive avoidance in C57bl/6J and DBA/2J mice
Petra J.J. Baarendse (2008)
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight.
James E. Dahlman (2014)
An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits.
Y. Chen (1996)
Assessing behavioural function following a pyramidotomy lesion of the corticospinal tract in adult mice
M. Starkey (2005)
Highly Stabilized Curcumin Nanoparticles Tested in an In Vitro Blood–Brain Barrier Model and in Alzheimer’s Disease Tg2576 Mice
Kwok Kin Cheng (2012)
Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.
U. Ungerstedt (1971)
NGF and anti-transferrin receptor antibody conjugate: short and long-term effects on survival of cholinergic neurons in intraocular septal transplants.
A. Granholm (1994)
EGCG Nanoparticles Attenuate Aluminum Chloride Induced Neurobehavioral Deficits, Beta Amyloid and Tau Pathology in a Rat Model of Alzheimer’s Disease
N. Singh (2018)
The tail suspension test: A new method for screening antidepressants in mice
L. Steru (2004)
Multifunctional receptor-targeted nanocomplexes for the delivery of therapeutic nucleic acids to the brain.
G. D. Kenny (2013)
Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment.
B. Gong (2004)
Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes*
N. D. Sonawane (2003)
Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles
S. C. Steiniger (2004)
Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
Hongliang Xin (2010)
The amygdala modulates the consolidation of memories of emotionally arousing experiences.
J. D. McGaugh (2004)
Self-assembled 20-nm (64)Cu-micelles enhance accumulation in rat glioblastoma.
J. Seo (2015)
Stereotypies in caged parrots, schizophrenia and autism: evidence for a common mechanism
J. Garner (2003)
MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson's disease.
C. Saraiva (2016)
Laser Desorption/Ionization Mass Spectrometric Imaging of Endogenous Lipids from Rat Brain Tissue Implanted with Silver Nanoparticles
L. Muller (2017)
Curcumin-loaded embryonic stem cell exosomes restored neurovascular unit following ischemia-reperfusion injury.
A. Kalani (2016)
Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia.
N. Swerdlow (1998)
Synthesis and characterization of a PAMAM dendrimer nanocarrier functionalized by SRL peptide for targeted gene delivery to the brain.
A. Zarebkohan (2015)
Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney. Possible implications in analgesic nephropathy.
J. Mohandas (1984)
Chemotherapeutic Drugs Released from Polymers: Distribution of 1,3-bis(2-chloroethyl)-l-nitrosourea in the Rat Brain
L. Fung (2004)
Convection-enhanced delivery of camptothecin-loaded polymer nanoparticles for treatment of intracranial tumors
Andrew J. Sawyer (2010)
Superparamagnetic Iron Oxide Nanoparticles Modified with Tween 80 Pass through the Intact Blood-Brain Barrier in Rats under Magnetic Field.
Yinping Huang (2016)
Squalenoyl Adenosine Nanoparticles provide Neuroprotection after Stroke and Spinal Cord Injury
Alice Gaudin (2014)
Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
Jianwei Guo (2011)
Oxidants, antioxidants and the ischemic brain
D. Warner (2004)
Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM Dendrimer.
Y. K. Katare (2015)
Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines.
N. Eddy (1953)
The phenomenology of experimentally induced amphetamine psychosis--preliminary observations.
B. Angrist (1970)
Spatial Localization Does Not Require the Presence of Local Cues
R. Morris (1981)
Biodistribution and Clearance of Stable Superparamagnetic Maghemite Iron Oxide Nanoparticles in Mice Following Intraperitoneal Administration
B. Pham (2018)
Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
Hyeong Jun Byeon (2016)
Lymphocytes infiltrating the CNS during inflammation display a distinctive phenotype and bind to VCAM-1 but not to MAdCAM-1.
B. Engelhardt (1995)
Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test
M. Olsson (1995)
Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice
R. Iancu (2005)
Neuroprotective potential of sesamol and its loaded solid lipid nanoparticles in ICV-STZ-induced cognitive deficits: behavioral and biochemical evidence.
Anand Kamal Sachdeva (2015)
Effects of strain, sex, and illumination on open-field behavior of rats.
F. Valle (1970)
Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice.
Yifeng Liu (2016)
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
X. Ying (2010)
Multifunctional Inorganic Nanoparticles: Recent Progress in Thermal Therapy and Imaging
Kondareddy Cherukula (2016)
Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides.
J. Li (2011)
The catalepsy test: its ups and downs.
P. Sanberg (1988)
Pluronic P85/F68 Micelles of Baicalein Could Interfere with Mitochondria to Overcome MRP2-Mediated Efflux and Offer Improved Anti-Parkinsonian Activity.
Tongkai Chen (2017)
Peroxide Modulation of Slow Onset Potentiation in Rat Hippocampus
J. Auerbach (1997)
Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.
Y. Çırpanlı (2011)
Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.
J. Kreuter (2004)
Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
Eameema Muntimadugu (2016)
A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
F. E. D'amour (1941)
Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease?
C. Lemere (2008)
Nanoparticles for Brain Drug Delivery
M. Masserini (2013)
Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants.
B. Petri (2007)
A self-assembling nanomaterial reduces acute brain injury and enhances functional recovery in a rat model of intracerebral hemorrhage.
Lynn Yan-Hua Sang (2015)
 Preparation of succinate dehydrogenase and reconstitution of succinate oxidase
T. E. King (1967)
Dexamethasone-Conjugated Polyamidoamine Dendrimer for Delivery of the Heme Oxygenase-1 Gene into the Ischemic Brain.
Pureum Jeon (2015)
Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.
A. Abuchowski (1977)
Immunological Properties of an Antibody Containing a Fluorescent Group.∗
A. H. Coons (1941)
Administration of substances to laboratory animals: routes of administration and factors to consider.
P. Turner (2011)
Cell-Penetrating Peptide-Modified Block Copolymer Micelles Promote Direct Brain Delivery via Intranasal Administration
T. Kanazawa (2011)
Formalin test in mice, a useful technique for evaluating mild analgesics
S. Hunskaar (1985)
The footfault test as a screening tool in the 6-hydroxydopamine rat model of Parkinson's disease
R. Silvestrin (2009)
Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model.
Yingzheng Zhao (2016)
The Paw test: an animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism.
B. Ellenbroek (1988)
Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease.
Kai-li Hu (2011)
Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment.
A. Zanotto-Filho (2013)
Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.
P. M. Friden (1991)
Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine
Rahul S. Nair (2012)
Haloperidol-loaded polysorbate-coated polymeric nanocapsules decrease its adverse motor side effects and oxidative stress markers in rats
D. Benvegnú (2012)
Longitudinal study of daily variation of rats' behavior in the elevated plus-maze
Miriam Mendonça Morato Andrade (2003)
The blood–brain barrier: an overview: Structure, regulation, and clinical implications
P. Ballabh (2004)
Lipid‐mediated siRNA delivery down‐regulates exogenous gene expression in the mouse brain at picomolar levels
Z. Hassani (2005)
Molecular histology analysis by matrix-assisted laser desorption/ionization imaging mass spectrometry using gold nanoparticles as matrix.
Ho-Wai Tang (2011)
Blood-brain barrier penetration and in vivo activity of an NGF conjugate.
P. Friden (1993)
Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.
S. Gelperina (2010)
Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor.
R. Prades (2012)
Curcumin micelles improve mitochondrial function in neuronal PC12 cells and brains of NMRI mice – Impact on bioavailability
S. Hagl (2015)
In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry.
L. Albertazzi (2013)
VTE on an elevated T-maze.
L. Jackson (1943)
Nanoparticle formulation improves the anticonvulsant effect of clonazepam on the pentylenetetrazole-induced seizures: behavior and electroencephalogram.
G. Leyva-Gómez (2014)
Novel surface modified polymer–lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation
C. Pardeshi (2013)
Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth.
M. Katakowski (2013)
Hydroperoxide metabolism in mammalian organs.
B. Chance (1979)
Lipid-DNA and lipid-polyelectrolyte mesophases: structure and exchange kinetics.
F. Artzner (2000)
Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy
M. Grounds (2008)
Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A.
Pratikkumar A. Patel (2013)
Antidepressant-like effects in various mice strains in the forced swimming test
D. David (2003)
Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effects.
T. Hekmatara (2009)
Manganese Superoxide Dismutase Deficiency Exacerbates Cerebral Infarction After Focal Cerebral Ischemia/Reperfusion in Mice: Implications for the Production and Role of Superoxide Radicals
G. Kim (2002)
Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ‘fear’-motivated behaviour
S. Handley (2004)
Impairment of brain mitochondrial function by hydrogen peroxide.
N. Sims (2000)
Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery.
D. Kim (2006)
Effects of neonatal dopamine depletion on sensory inhibition in the rat
K. Stevens (1996)
The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury.
Li-xia Zhao (2013)
The History of Histology: A Brief Survey of Sources
B. Bracegirdle (1977)
Tau-Targeted Multifunctional Nanocomposite for Combinational Therapy of Alzheimer's Disease.
Q. Chen (2018)
Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress
R. Floyd (1992)
Molecular mechanisms of amyloidosis.
G. Merlini (2003)
A self-assembly peptide nanofibrous scaffold reduces inflammatory response and promotes functional recovery in a mouse model of intracerebral hemorrhage.
N. Zhang (2016)
Advances in Stimulus‐Responsive Polymeric Materials for Systemic Delivery of Nucleic Acids
Minjie Sun (2018)
Long-term sensitization of apomorphine-induced rotation behavior in rats with dopamine deafferentation or excitotoxin lesions of the striatum
Jennifer M. Klug (1993)
Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route.
Yasmine M Gabal (2014)
Radiolabeling approaches of nanoparticles with (99m) Tc.
D. Psimadas (2013)
Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo
Y. Chen (2016)
Inorganic nanoparticles as carriers for efficient cellular delivery
Z. P. Xu (2006)
Magnetic micelles for DNA delivery to rat brains after mild traumatic brain injury.
Mahasweta Das (2014)
Shortened pain response time following repeated algesiometric tests in rats
Y. Lai (1982)
Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles.
Shaobo Ruan (2015)
T7 Peptide-Functionalized PEG-PLGA Micelles Loaded with Carmustine for Targeting Therapy of Glioma.
Yunke Bi (2016)
A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease.
Fanfei Meng (2015)
Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting.
S. Vyas (2001)
Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion
Kouji Matsuura (1997)
Polymeric nanoparticles for drug delivery to the central nervous system.
T. Patel (2012)
Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma
J. Tang (2017)
Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.
Shu-Hui Hsu (2010)
Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer’s disease
M. Ismail (2013)
In vivo bioluminescence imaging.
A. Sato (2004)
Redox nanoparticle treatment protects against neurological deficit in focused ultrasound-induced intracerebral hemorrhage.
Pennapa Chonpathompikunlert (2012)
Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration
T. Miyazawa (2015)
Progressive age‐related development of Alzheimer‐like pathology in APP/PS1 mice
F. Trinchese (2004)
Glutathione in Cancer Biology and Therapy
J. Estrela (2006)
Early Glasgow Outcome Scale scores predict long-term functional outcome in patients with severe traumatic brain injury.
J. King (2005)
Recent insights in the use of nanocarriers for the oral delivery of bioactive proteins and peptides
P. Batista (2018)
[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease
A. Siderowf (2005)
Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity.
B. Costall (1978)
Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced dyskinesia
A. D. Andersen (2017)
Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on
A. Carobrez (2005)
Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas.
H. Brem (1991)
The corticotrophin‐releasing factor‐like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease
A. Abuirmeileh (2007)
Effects of ultra-low doses of morphine, naloxone and ethanol on morphine state-dependent memory of passive avoidance in mice
K. Tayebi Meybodi (2005)
Individual differences in the hotplate test and effects of habituation on sensitivity to morphine
M. Plone (1996)
Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
Hongliang Xin (2012)
Nanoerythropoietin Is 10-Times More Effective Than Regular Erythropoietin in Neuroprotection in a Neonatal Rat Model of Hypoxia and Ischemia
H. Chen (2012)
Convection-enhanced delivery of a synthetic retinoid Am80, loaded into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma xenografts.
Michiko Yokosawa (2010)
GRP78 enabled micelle‐based glioma targeted drug delivery
D. Ran (2017)
An improved method for tail-flick testing with adjustment for tail-skin temperature
A. Tjølsen (1989)
Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles
T. Schneider (2008)
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.
L. C. Green (1982)
mPEG-PLA/TPGS mixed micelles via intranasal administration improved the bioavailability of lamotrigine in the hippocampus
Anan Yu (2017)
A Review of Clinical Translation of Inorganic Nanoparticles
Aaron C. Anselmo (2015)
Tf-lipoplex-mediated NGF gene transfer to the CNS: neuronal protection and recovery in an excitotoxic model of brain injury
M. D. Cruz (2005)
Phenytoin carried by silica core iron oxide nanoparticles reduces the expression of pharmacoresistant seizures in rats.
Argelia Rosillo-de la Torre (2015)
Convection-enhanced delivery of SN-38-loaded polymeric micelles (NK012) enables consistent distribution of SN-38 and is effective against rodent intracranial brain tumor models
R. Zhang (2016)
The role of glutamate in anxiety and related disorders.
B. Cortese (2005)
Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein
S. Fleming (2004)
Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
Hongliang Xin (2011)
Defining small differences in efficacy between anti-parkinsonian agents using gait analysis: a comparison of two controlled release formulations of levodopa/decarboxylase inhibitor.
C. Weller (1993)
Catatonia. I. Rating scale and standardized examination
G. Bush (1996)
Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain
Ryuta Saito (2005)
Factors affecting grip strength testing.
J. Maurissen (2003)
Congo red and protein aggregation in neurodegenerative diseases
Petrea Frid (2007)
Nanoparticle‐mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia‐reperfusion injury
M. K. Reddy (2009)
Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration
H. Gao (2008)
The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain.
R. Huang (2008)
Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles
J. Kreuter (2004)
Comparative Analysis of H&E and Prussian Blue Staining in a Mouse Model of Cerebral Microbleeds
S. Liu (2014)
Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine.
B. Wilson (2010)
Cyclic RGD-polyethylene glycol-polyethylenimine for intracranial glioblastoma-targeted gene delivery.
C. Zhan (2012)
Origins and Phylogenetic Relationships of the Laboratory Mouse
J. Guénet (2012)
Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.
R. Lebovitz (1996)
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
A. Gulyaev (2004)
Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles
R. Alyautdin (2004)
Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.
J. Bederson (1986)
Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease.
C. Zhang (2014)
Morphine catalepsy in the rat: relation to striatal dopamine metabolism.
K. Kuschinsky (1972)
Nanoparticles--a historical perspective.
J. Kreuter (2007)
Conditioned avoidance response in the development of new antipsychotics.
M-L G Wadenberg (2010)
Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: Evidence that at a very low dose haloperidol acts as an indirect dopamine agonist
F. Dias (2012)
Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive
E. Chesler (2002)
Brain molecular aging, promotion of neurological disease and modulation by Sirtuin5 longevity gene polymorphism
C. Glorioso (2011)
Brain-Penetrating Nanoparticles Improve Paclitaxel Efficacy in Malignant Glioma Following Local Administration
E. Nance (2014)
Biocompatible custom ceria nanoparticles against reactive oxygen species resolve acute inflammatory reaction after intracerebral hemorrhage
D. W. Kang (2017)
CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury
T. Schallert (2000)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
H. Valadi (2007)
Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats.
V. Kakkar (2013)
Effect of mesenchymal stem cells and galantamine nanoparticles in rat model of Alzheimer's disease.
S. Misra (2016)
Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: Physicochemical and in vivo performances.
Sanela M. Đorđević (2017)
Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43
Azusa Uchida (2012)
Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease
W. Zhang (2005)
Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel
B. Wang (2015)
Reliability of malondialdehyde as a biomarker of oxidative stress in psychological disorders
Maryam Khoubnasabjafari (2015)
Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3α,5α-THP
C. Frye (2000)
Intranasal drug delivery of small interfering RNA targeting Beclin1 encapsulated with polyethylenimine (PEI) in mouse brain to achieve HIV attenuation
M. Rodríguez (2017)
Receptor-Mediated Gene Targeting to Tissues In Vivo Following Intravenous Administration of Pegylated Immunoliposomes
N. Shi (2004)
Convection-Enhanced Delivery of Carboplatin PLGA Nanoparticles for the Treatment of Glioblastoma
Azeem Arshad (2015)
The Behavior of Organisms: An Experimental Analysis
B. Skinner (2016)
Bioimaging of metals in brain tissue by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) and metallomics.
J. S. Becker (2010)
Functional subdivisions of the rat somatic sensorimotor cortex
T. M. Barth (1990)
Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice
V. Castagné (2010)
Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
T. Parikh (2010)
Object recognition test in mice
M. Léger (2013)
Improved method for combination of immunocytochemistry and Nissl staining
A. Kádár (2009)
An intrinsic therapy of gold nanoparticles in focal cerebral ischemia-reperfusion injury in rats.
Zhengxia Liu (2013)
Curcumin-loaded chitosan-alginate-STPP nanoparticles ameliorate memory deficits and reduce glial activation in pentylenetetrazol-induced kindling model of epilepsy
Mona Hashemian (2017)
Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s Disease
Y. Liu (2013)
Enhanced Tumour Uptake of Doxorubicin Loaded Poly(butyl cyanoacrylate) Nanoparticles in Mice Bearing Dalton's Lymphoma Tumour
L. H. Reddy (2004)
In vitro and in vivo evaluation of functionalized chitosan-Pluronic micelles loaded with myricetin on glioblastoma cancer.
G. Wang (2016)
Impaired learning resulting from Respiratory Syncytial Virus infection
J. Espinoza (2013)
Efficient delivery of docetaxel for the treatment of brain tumors by cyclic RGD-tagged polymeric micelles.
A. Li (2015)
Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?
J. Kreuter (2014)
Performance of different mouse strains in an object recognition task
A. Şık (2003)
The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats
D. Dubuisson (1978)
Synthesis of Alginate-Curcumin Nanocomposite and Its Protective Role in Transgenic Drosophila Model of Parkinson's Disease
Y. Siddique (2013)
Intravenous Administration of Cilostazol Nanoparticles Ameliorates Acute Ischemic Stroke in a Cerebral Ischemia/Reperfusion-Induced Injury Model
N. Nagai (2015)
HemiParkinson analogue rats display active support in good limbs versus passive support in bad limbs on a skilled reaching task of variable height.
E. Miklyaeva (1996)
The application of magnetic nanoparticles for the treatment of brain tumors
K. Mahmoudi (2014)
The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals
Y. Wang (2017)
This paper is referenced by
Nanotechnology enabled regenerative medicine for neurological disorders.
T. Lowe (2019)